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Sun~nary 
Bright artificial light is a treatment for seasonal depression. 
Eleven (ii) rats were exposed to bright artificial light (11,500 lux) 
for two consecutive weeks. The thermic response to nicotine was 
measured prior to light exposure and after one and two weeks of 
treatment. The thermic response to nicotine at baseline was -1.69 ! 
0.25°C (mean + SEM). The thermic response to nicotine was -0.66 ! 
0.12°C (p < 0?002) after one and +0.31 ± 0.140C (p < 0.000025) after 
two weeks of light exposure. The change in termperature was 
different between weeks one and two (p < 0.000025). The exposure of 
animals to constant light at an intensity of 300 lux did not blunt 
the hypothermic response to nicotine. These findings suggest that 
bright artificial light, like other antidepressant treatments, 
produces subsensitivity of a nicotinic mechanism involved in the 
regulation of core temperature. 
Seasonal affeetive disorder (SAD) is a recently described syndrome 
characterized by recurrent depressions which occur at the same time each year 
(i). This syndrome responds to daily treatment with two-six hours of bright 
artificial light (1-5). A mechanism accounting for the efficacy of this 
treatment or an effect linking it with other forms of antidepressant treatment 
has not been identified. Phenelzine (6), desipramine (6), and fluoxetine (7) 
produced subsensitivity to the hypothermic effects of nicotine. Thus, we 
sought to determine whether exposure to bright artificial light alters the 
hypothermic response to nicotine in rats subjected to artifical light at an 
intensity of 11,500 lux for two weeks. 
Materials and Methods 
Experiment i: This experiment involved ii adult, male Sprague-Dawley rats 
weighting 312.7 ! 7.8 g (mean ! SEM). The hypothermic response to nicotine 
(base), 1 mg/kg ip, was measured at I0 minute intervals for 120 minutes at 
baseline (i.e., prior to exposure to bright artificial light), after one and 
two weeks of treatment, and one and two weeks after withdrawal. 
This work was performed while Dr. Dilsaver was at the University of Michigan. 
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Core temperature was measured using intraperitoneally implanted Model VM 
Mini-Mitters (Mini-Mitter Co., Sun River, OR). These telemetric thermosensors 
emit radio waves, detectable with a standard AM receiver, at a rate directly 
proportional to temperature. The animals were allowed five days to recover 
from the surgical procedure prior to starting the study. The reliability and 
validity of this method of measuring temperature is described elsewhere (8). 
Bright artificial light consisted of 11,500 lux full-spectrum light emitted 
24 hours/day for 14 days from a bank of eight 122 cm long Vitalight tubes 
suspended 50 cm above the animals. This unit (Duro Test Co., North Bergen, NJ, 
Model 5599) is used to treat patients with SAD. Temperature under the unit was 
23°C. 
Experiment 2: Experiment 2 involved the use of 10 adult male Sprague- 
Dawley rats weighting 248.0 ~ 14.9 g. This involved the exposure of animals to 
standard fluorescent light at an intensity of 300 lux 24 hours a day for 14 
days. This was designed to show that changes in circadian rhythm due to light 
exposure do not account for a change in sensitivity to nicotine. 
Experiment 3: A control experiment was designed to assess whether multiple 
injections of nicotine, at the dose and frequency of administration used in 
this article, might produce detectable carryover effects. Model VM Mini- 
mitters were implanted into 8 adult, male Sprague-Dawley rats (mean weight 
SEM = 303 ~ 9.4g). The animals were allowed 5 days to recover. The animals 
then received nicotine (base), 1 mg/kg ip, every 7 days for 21 days. Core 
temperature was measured every i0 minutes for 120 minutes after the first 
(baseline) and fourth injections of nicotine. 
Baseline core temperature for a Kiven nicotine challenge is defined as the 
core temperature immediately prior to the injection of nicotine (t = 0). The 
mean thermic response of each individual animal was determined by pairing the 
core temperature at t = 0 with the core temperature I0, 20, 30, ..., 120 
minutes after the administration of nicotine. These multiple measurements 
allow us to make probability statements about the thermic responsiveness of 
each individual animal relative to the "prelight treatment phase," after one or 
two weeks of bright light exposure or after two weeks as opposed to one week of 
light treatment. The mean hypothermic response of each animal at each point in 
the study was entered into an analysis to determine the level of significance 
of the sample's thermic response. Student's paired t-tests were used for this 
purpose. All measures of variance in the text refer to the standard error of 
the mean (SEM). 
Results 
Experiment i: Table I summarizes the individual responses of all ii 
animals. Eight (8) animals demonstrated significant blunting of the 
hypothermic response, and two demonstrated a trend toward a significant 
decrease after one week of bright light exposure. All Ii animals exhibited 
blunting of the response at the 0.0003 level or less after two weeks of 
treatment. Moreover, I0 animals exhibited significantly greater blunting of 
the hypothermic response after two weeks of light exposure than after one week 
of treatment. Interestingly, 8 of the ii animals actually showed a mean 
increase in core temperature in response to nicotine (rather than a hypothermic 
response) after two weeks of light treatment. 
The core temperature at t = 0 of the sample prior to exposure to bright 
artificial light, after one and two weeks of treatment and one and two weeks of 
withdrawal, was 36.7 + 0.180C, 37.5 ~ 0.13°C, 37.0 ~ 0.17°C, 36.7 ~ 0.160C, and 
37.0 + 0.16°C, respectively. The mean thermic response of the sample was -1.69 
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0.25°C at baseline and -0.66 ! 0.12°C (p < 0.0002, t = 4.24, df = I0) and 
+0.32 ! 0.14°C (p < 0.00003, t = 7.35, df = 10) after one and two weeks of 
treatment, respectively. The difference in thermic responsiveness, was also 
significantly different between weeks one and two (p < 0.0003, t = 5.57, df = 
I0). The thermic response one week after dicontinuing treatment was -0.26 + 
0.11°C. This differed both from baseline (p < 0.00006, t =6.75, df = I0) and 
the response after two weeks of phototherapy (p < 0.015, t = 3.11, df = i0). 
The thermic response two weeks after discontinuing light was -0.56 ! 0.17°C. 
This is different from the response after two weeks of treatment at a < 0.0015 
(t = 4.33, df = i0). Thus, there was a significant tendency for the animals to 
respond to the withdrawal of bright artificial light by becoming more sensitive 
to nicotine. 
Experiment 2: Mean core temperature at t = 0 prior to challenge with 
saline and the baseline challenge with nicotine was 37.2 + 0.32°C and 37.1 + 
0.25°C. Mean core temperature prior to nicotine challenges 2 and 3 (i.e., 
after one and two weeks of exposure to 300 lux light ) was 36.9 ! 0.28°C and 
36.6 + 0.30°C, respectively. The mean thermic response of the sample to saline 
(i mlTkg ip was +0.30 ~ 0.10°C (p < 0.02, t = 3.11, df = 9). The mean thermic 
response of the sample to nicotine was -i.0 ! 0.11°C at baseline. This 
differed from the response to saline at a < 0.000001 (t = 13.63, df = 9). The 
mean thermic responses to nicotine after one, -0.9 ! 0.11°C (p > 0.80, t = 
0.24, df = 9), and two, -1.1 ! 0.07°C (p > 0.30, t = 1.09, df = 9), weeks of 
light treatment did not differ from baseline. 
Experiment 3: Mean core temperature at baseline was 37.5 + 0.60°C. The 
mean thermic response to nicotine, 1 mg/kg ip, was -1.37 + 0.2~°C (n = 8) when 
the sample was first challenged and -1.32 ! 0.20°C (n = 8~ after the fourth 
challenge (p > .50, t = 0.67, df = 7). Thus, multiple injections did not 
produce subsensitivity to subsequent challenges. 
Discussion 
The data presented in this article indicate that bright artificial light 
(11,500 lux) but not standard fluorexcent light (300 lux) potently produces 
subsensitivity of a nicotinic cholinergic mechanism involved in the regulation 
of core temperature. The potential importance of this finding is highlighted 
by data indicating that antidepressants such as fluoxetine (7), desipramine 
(6), and phenelzine (6) also produce subsensitivity to nicotine. 
Chronic treatment with bright artificial light, 11,500 lux, produced 
subsensitivity to the hypothermic effects of nicotine, but light at an 
intensity of 300 lux did not. This suggests that light intensity is a critical 
variable. Further, this observation argues against the hypothesis that the 
effects we measured result from alterations in circadian rhythms consequent to 
constant light exposure. The intensity of light in the rat cages in our 
vivarium is exactly 300 lux. Sprague-Dawley rats demonstrate clear-cut 
circadian changes in motor activity and core temperature in response to turning 
the lights in the vivarium on or off. Thus, we propose that the results 
presented in this article are due to the effects of bright artificial light 
rather than light itself. Further, the documentation that multiple injections 
of nicotine, i mg/kg ip, every 7 days for 21 days (i.e., 4 doses) does not 
alter the hypothermic response also suggests that the outcome is not an 
artifact of the experimental design. 
Janowsky et al. (9) proposed that depressive disorders are related to a 
defect in cholinergic mechanisms. Specifically, the depressed state in some 
individuals may be characterized by cholinergic overdrive. Sitaram et al. (i0) 
observed that euthymic patients exhibit accelerated onset of REM sleep relative 
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to normal subjects in response to cholinomimetic challenge. This indicates 
that at least certain forms of affective illness involve state independent 
supersensitivity of a central muscarinic mechanism. These and other data 
supporting the cholinergic hypothesis of depression were recently summarized 
(11,12). It is, however, essential to emphasize that the relative roles of 
nicotinic and muscarinic cholinergic mechanisms in the pathophysiology of 
affective disorders is not known. Further, the classic form of the cholinergic 
hypothesis focuses exclusively on muscarinic mechanisms. 
There are indeed sites in the mammalian brain which bind [3HI nicotine 
(13), a-bungarotoxin (14), and neosurugatorin (15), but a receptor with the 
structural properties characterizing the peripheral nicotinic receptor has not 
been identified. Two possibilities exist. Nicotinic and muscarinic agonists 
may act at sites which have mixed nicotinic-muscarinic responsiveness. This 
suggests that subsensitivity to nicotine would be accompanied by subsensitivity 
to muscarinic agonists. We currently are evaluating this possibility. It is 
also possible that the development of subsensitivity to nicotine is an 
epiphenomenon. Activation of nicotinic sites releases norepinephrine in the 
hypothalamus (16) and dopamine within the mesolimbic and nigrostriatal tracts 
(17). Should treatment with bright artificial light enhance the sensitivity of 
catecholaminergic mechanisms, a compensatory response may be subsensitizaton of 
those nicotinic mechanisms capable of activating them. 
Patients with SAD are generally treated with full-spectrum light at an 
intensity of 2,500 lux. There are distinct advantages to using brighter light 
in a preliminary study. Our objective was to determine whether bright light as 
opposed to standard room lighting affects subsensitivity to nicotine. The 
higher the "dose," one might suppose, the lower the probability of a Type II 
error ("bright artificial light does not produce subsensitivity to the thermic 
effects of nicotine"). It is now known that treatment with full-spectrum light 
at an intensity of ll,500 lux results in decreased sensitivity to nicotine. 
Thus, it would now be reasonable to evaluate the effects of various intensities 
of illumination and the effects of administering light for circumscribed 
periods of time during the day. 
The light unit we used delivers light at an intensity of 2,500 lux when it 
is 122 cm from the face of patient. In order to deliver light at an intensity 
of ll,500 lux, we suspended the unit 50 cm above the animals. A patient does 
not experience discomfort when the unit is placed this distance from the face. 
It would, therefore, be feasible to use a higher "dose" or brighter light 
should studies suggest that an intensity of illumination greater than 2,500 lux 
is preferable. 
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